All News

Found 2,749 articles

• Precision NanoSystems Unveils Innovative System For Scale-Up Manufacture Of Nanomedicines

  3/8/2017

• The Jackson Laboratory Release: JAX Receives Federal Grant To Improve Crispr-Cas9 Accuracy, Efficiency And Reliability

  3/7/2017

• Applied StemCell, Inc. Announces The Appointment Of Dr. Michele Calos, Stanford Professor And Vice President Of The American Society Of Gene And Cell Therapy To Its Scientific Advisory Board (SAB)

  3/6/2017

• CRISPR/Cas9 Startup Exonics Therapeutics Launches in Boston

  2/28/2017

• European Patent Office To Grant CRISPR-Cpf1 Patent To Broad Institute, MIT, And Harvard

  2/28/2017

• CRISPR Announces The Appointment Of Jon Terrett, Ph.D. To Head Of Immuno-Oncology Research And Translation

  2/28/2017

• Vycellix And H. Lee Moffitt Cancer Center & Research Institute Announce A Collaborative Research Study To Evaluate Novel Product Candidates For Improving Adoptive Cell Immunotherapies For Cancer

  2/27/2017

• Future Biotech Giants: 11 Life Science Entrepreneurs Under 30

  2/24/2017

• ToolGen Highlights Study Results Demonstrating Utility Of AAV-Compatible Cas9 System In Vivo Genome Editing

  2/22/2017

• Synthego Release: Survey: Over 80 Percent Of New CRISPR Users Are Conducting Gene Editing For The First Time

  2/20/2017

• Abeona Therapeutics Provides Update From ABO-102 Phase I/II MPS IIIA Clinical Trial At The 13th Annual WORLDSymposium 2017

  2/17/2017

• This is Why the Decision on Who Invented CRISPR Matters

  2/16/2017

• CRISPR, Intellia, Caribou Biosciences And ERS Genomics Provide Update On CRISPR/Cas9 U.S. Patent Interference Proceedings And Grants Of Corresponding Patents In The U.K.

  2/16/2017

• The Alliance for Regenerative Medicine (ARM) Releases Statement In Response To National Academies Report On Human Genome Editing

  2/15/2017

• This is How 47 Scientists Were Selected for the Chan-Zuckerberg Biohub

  2/13/2017

• Bill Gates Talks of Biotech as Top 3 Career Choices

  2/1/2017

• Abeona Therapeutics Enrolls First High Dose Subject In Ongoing Phase 1/2 Gene Therapy Clinical Trial In Sanfilippo Syndrome Type A

  2/1/2017

• Agenovir Names Bolyn Hubby, Ph.D., As Chief Scientific Officer

  1/31/2017

• Tony Coles, M.D., Elected To Regeneron Board Of Directors

  1/31/2017

• Cellecta, Inc. Release: Biotech Receives Phase II NIH SBIR Grant To Develop Advanced CRISPR/Cas9 Genome-Wide sgRNA Library Screening Platform

  1/26/2017